Wolf G, Trüb T, Ottinger E, Groninga L, Lynch A, White M F, Miyazaki M, Lee J, Shoelson S E
Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Biol Chem. 1995 Nov 17;270(46):27407-10. doi: 10.1074/jbc.270.46.27407.
PTB domains are non-Src homology 2 (SH2) phosphotyrosine binding domains originally described in the receptor tyrosine kinase substrate, Shc. By serial truncation, we show that a 174-residue region of Shc p52 (33-206) has full PTB activity. We also show that a 173-residue region of insulin receptor substrate-1 (IRS-1; residues 144-316) has related PTB activity. In vitro both domains bind directly to activated insulin receptors. Binding is abrogated by substitution of Tyr-960 and selectively inhibited by phosphopeptides containing NPXY sequences. Phosphopeptide assays developed to compare PTB domain specificities show that the Shc PTB domain binds with highest affinity to psi XN beta 1 beta 2 pY motifs derived from middle T (mT), TrkA, ErbB4, or epidermal growth factor receptors (psi = hydrophobic, beta = beta-turn forming); the IRS-1 PTB domain does not bind with this motif. In contrast, both the Shc and IRS-1 PTB domains bind psi psi psi XXN beta 1 beta 2pY sequences derived from insulin and interleukin 4 receptors, although specificities vary in detail. Shc and IRS-1 are phosphorylated by distinct but overlapping sets of receptor-linked tyrosine kinases. These differences may be accounted for by the inherent specificities of their respective PTB domains.
PTB结构域是非Src同源2(SH2)磷酸酪氨酸结合结构域,最初在受体酪氨酸激酶底物Shc中被描述。通过连续截短,我们发现Shc p52的一个174个残基的区域(33 - 206)具有完整的PTB活性。我们还发现胰岛素受体底物-1(IRS-1;残基144 - 316)的一个173个残基的区域具有相关的PTB活性。在体外,这两个结构域都直接与活化的胰岛素受体结合。Tyr-960的取代会消除这种结合,并且含有NPXY序列的磷酸肽会选择性地抑制这种结合。为比较PTB结构域特异性而开发的磷酸肽分析表明,Shc PTB结构域与源自中T(mT)、TrkA、ErbB4或表皮生长因子受体的ψXNβ1β2pY基序具有最高亲和力结合(ψ = 疏水,β = 形成β-转角);IRS-1 PTB结构域不与该基序结合。相反,Shc和IRS-1 PTB结构域都与源自胰岛素和白细胞介素4受体的ψψψXXNβ1β2pY序列结合,尽管在细节上特异性有所不同。Shc和IRS-1被不同但重叠的一组受体连接的酪氨酸激酶磷酸化。这些差异可能由它们各自PTB结构域的固有特异性来解释。